Net Cash Provided by (Used in) Operating Activities |
-7.49K |
USD |
-694% |
Q1 2022 |
Q1 2022 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q1 2022 |
Q1 2022 |
Common Stock, Shares Authorized |
740M |
shares |
0% |
Q3 2022 |
Q3 2022 |
Common Stock, Shares, Issued |
467M |
shares |
+111% |
Q3 2022 |
Q3 2022 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2022 |
Q3 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-7.46K |
USD |
-669% |
Q1 2022 |
Q1 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6 |
USD |
-99.5% |
Q3 2022 |
Q3 2022 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Valuation Allowance |
1.31M |
USD |
+2797% |
Q3 2022 |
Q3 2022 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-6.05M |
USD |
-1403344% |
Q3 2022 |
Q3 2022 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2022 |
Q1 2022 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2022 |
Q3 2022 |
Additional Paid in Capital |
6.36M |
USD |
+54780% |
Q3 2022 |
Q3 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2022 |
Q3 2022 |
Interest Expense |
0 |
USD |
-100% |
Q3 2022 |
Q3 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2022 |
Q3 2022 |